JohnConcatoMD

Critical Care Medicine

Professor, Internal Medicine, Yale University School of Medicine

Dr. Concato is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
950 Campbell Ave
Building 35a Mailcode 151B
West Haven, CT 06516
Phone+1 203-932-5711

Dr. Concato is an Adjunct Professor of Medicine at Yale School of Medicine. He was most recently Associate Director for Real-World Evidence Analytics in the Office of Medical Policy (OMP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA). Dr. Concato was also the founding director of the CDER Center for Real-World Evidence Innovation (CCRI). Prior to joining FDA in 2019, for three decades he was a clinician, educator, researcher, and center director at Yale University and the U.S. Department of Veterans Affairs. Dr. Concato completed his medical education at New York University (NYU) School of Medicine in 1985, followed by a residency and chief residency in Internal Medicine at NYU/Bellevue Hospital and a fellowship as a Robert Wood Johnson Clinical Scholar at Yale-New Haven Hospital.

Yale-New Haven HospitalFellowship, Robert Wood Johnson Clinical Scholar, 1989 - 1991
NYU Grossman School of MedicineResidency, Internal Medicine, 1985 - 1989
New York University School of MedicineClass of 1985

PubMed

Use of sensitivity analyses to assess uncontrolled confounding from unmeasured variables in observational, active comparator pharmacoepidemiologic studies: a systemati...
Chase D Latour, Megan Delgado, I-Hsuan Su, Catherine Wiener, Clement O Acheampong
American Journal of Epidemiology. 2025-02-05
1 citations
Prescription Medication Use Among Older Adults in the US.
Gabriel K Innes, Cynthia L Ogden, Victor Crentsil, John Concato, Tala H Fakhouri
JAMA Internal Medicine. 2024-09-01
Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.
Marijo Kambere, Hong Vu, Dana Kappel, Kukhwa Oh, Philip Budashewitz
Therapeutic Innovation & Regulatory Science. 2024-09-01

Journal Articles

AUDIT‐C and ICD Codes as Phenotypes for Harmful Alcohol Use: Association with ADH1B Polymorphisms in Two U.S. Populations
David A Fiellin, William C Becker, Joel Gelernter, Henry R Kranzler, Ning Sun, John Concato, Addiction